Global publication trends in ophthalmic genetics and gene therapy research: A Scientometric analysis / Tendências globais de publicação de pesquisas sobre genética oftálmica e terapia genética: uma análise cientométrica

ABSTRACT Objective: A scientometric analysis produced in ophthalmic genetics and gene therapy research is lacking. The purpose of this study is to present a holistic analysis of ophthalmic genetics literature. Methods: The data used in this study were obtained from the Web of Science (WoS) Core Collection. All published documents between 1975-2019 were included. The data exported from WoS enabled the extensive details of ophthalmic genetics related literature including countries, institutions, authors, citations and keywords. Scientometric network maps of keywords and also country and institution co-authorships were created with free software. Global contributions of the countries to the ophthalmic genetics literature were shown by a graphic. Results: The search query revealed a total of 2322 documents. Most of the documents were original articles (75.75%). USA was the leading country by producing 45.39% of all documents in ophthalmic genetics research followed by UK, Germany, China and France. Pennsylvania University was the most contributing institution in the literature (5.25%) followed by University College London and Moorfields Eye Hospital. The average citations per item was 29.4. The most used keywords over a 40-year period were 'family', 'cell', 'photoreceptor' and 'expression'. Conclusions: USA and UK dominated the ophthalmic genetics research. A substantial increase in the number of published documents in this field were observed after 2010.

RESUMO Objetivo: A literatura carece de análise cienciométrica produzida em genética oftálmica e de pesquisa em terapia genética. O objetivo deste estudo é apresentar uma análise holística da literatura genética oftálmica. Métodos: Os dados utilizados neste estudo foram obtidos na base de dados Web of Science (WoS) Core Collection. Todos os documentos publicados entre 1975 e 2019 foram incluídos na análise. Os dados exportados da WoS viabilizaram acesso a amplos detalhes da literatura relacionada à genética oftálmica, incluindo países, instituições, autores, citações e palavras-chave. Mapas de rede cienciométrica foram criados por meio de software gratuito, com base em palavras-chave e em coautorias de países e instituições. As contribuições globais dos países para a literatura sobre genética oftálmica foram apresentadas em gráfico. Resultados: a busca por pesquisas revelou um total de 2.322 documentos cuja maioria eram artigos originais (75,75%). Os EUA foram o país que mais produziu artigos sobre o tema, com 45,39% de todos os documentos em pesquisa genética oftálmica; ele foi seguido pelo Reino Unido, Alemanha, China e França. A Universidade da Pensilvânia foi a instituição que mais contribuiu para a literatura (5,25%), e foi seguida pela University College London e pelo Moorfields Eye Hospital. A média de citações por item foi de 29,4. As palavras-chave mais usadas em um período de 40 anos foram 'família', 'célula', 'fotorreceptor' e 'expressão'. Conclusões: Os EUA e o Reino Unido dominaram a pesquisa em genética oftálmica. Após 2010, observou-se um aumento substancial no número de documentos publicados nessa área.

Levels of Evidence: What Should Ophthalmologists Know? / Níveis de evidência: O que os Oftalmologistas devem saber?

Abstract Facing an enormous influx of information from medical research, clinicians need to differentiate robust study findings from spurious ones. The levels of evidence are an important component of Evidence-Based Medicine. Understanding the levels helps the Ophthalmologist to prioritize information and make right clinical decisions. The aim of this article is to describe the hierarchy of studies regarding their scientific evidence focusing on ophthalmology.

Resumo Em face a um enorme influxo de informações de pesquisa médica, os clínicos precisam diferenciar os achados de estudos robusto dos espúrios. Os níveis de evidência são um componente importante da Medicina Baseada em Evidências. Compreender os níveis ajuda ooftalmologista a priorizar as informações e tomar decisões clínicas corretas. O objetivo deste artigo é descrever a hierarquia dosestudos em relação à evidência científica com enfoque na oftalmologia.

Vision and the Nobel Prize / A visão e Prêmio Nobel

ABSTRACT The Nobel Prize is the world's foremost honor for scientific advances in medicine and other areas. Founded by Alfred Nobel, the prizes have been awarded annually since 1901. We reviewed the literature on persons who have won or competed for this prize in subjects related to vision and ophthalmology. The topics were divided into vision physiology, diagnostic and therapeutic methods, disease mechanism, and miscellaneous categories. Allvar Gullstrand is the only ophthalmologist to win a Nobel Prize; he is also the only one to receive it for work in ophthalmology. Other ophthalmologists that have been nominated were Hjalmar Schiötz (tonometer), Karl Koller (topical anesthesia), and Jules Gonin (retinal detachment). Other scientists have won the prize for eye-related research: Ragnar Granit, Haldan Hartline and George Wald (chemistry and physiology of vision), and David Hubel and Torsten Wiesel (processing in the visual system). Peter Medawar is the only person born in Brazil to have won the Nobel Prize.

RESUMO O Prêmio Nobel é a principal honraria do mundo para avanços científicos em medicina e outras áreas. Fundada por Alfred Nobel, os prêmios são concedidos anualmente desde 1901. Revisamos a literatura sobre pessoas que ganharam ou competiram por esse prêmio em assuntos relacionados à visão e oftalmologia. Os tópicos foram divididos em fisiologia da visão, métodos diagnósticos e terapêuticos, mecanismo de doenças e variados. Allvar Gullstrand não é o único oftalmologista a ganhar um Nobel, porém é o único a recebê-lo por contribuições na oftalmologia. Outros oftalmologistas foram nomeados: Hjalmar Schiötz (tonometro), Karl Koller (anestesia tópica) e Jules Gonin (descolamento da retina). Outros cientistas ganharam o prêmio com pesquisas relacionadas à visão: Ragnar Granit, Haldan Hartline e George Wald (química e fisiologia da visão); David Hubel e Torsten Wiesel (processamento no sistema visual). Peter Medawar é a única pessoa que nasceu no Brasil a ganhar o prêmio.

Análisis de la salud visual de los colombianos 2011-2012 / Analysis of colombian visual health in 2011 - 2012

Objetivo: analizar la tendencia de las enfermedades que afectan la salud visual y su impacto económico para Colombia. Método: con la información de cinco instituciones nacionales que proporcionaron las bases de datos de la población atendida en los años 2011 y 2012; se construyó una única base de datos. Con la información ya compilada, se realizó un análisis retrospectivo que incluyó la caracterización de la población, frecuencia diagnóstica, tipo de procedimientos y costos. Los diagnósticos encontrados fueron agrupados según la clasificación CIE-10 para enfermedades del ojo. El total de los registros se comparó con los datos de los registros individuales de prestación de servició de salud, para estos mismos años, y se obtuvo un costo promedio de las enfermedades. Resultados: el total de la base analizada estaba conformada por 94.661 pacientes, atendidos en el año 2011 y 73.433 pacientes para el año 2012. Se encontró que el total de pacientes incluidos en este análisis corresponden al 8,2 % para el año 2011 y al 9,9 % del total de los registros individuales de prestación de servició de salud para el año 2012. La distribución de los principales diagnósticos encontrados en consulta externa para los dos años analizados, arrojó que los trastornos de refracción ocupan el primer lugar, seguidos de cataratas para ambos años. Conclusiones: se evidencia la necesidad de contar con investigaciones que muestren la situación de salud visual de la población con representatividad nacional, para poder generar planes, que promuevan el control, seguimiento y prevención de las enfermedades de salud visual en Colombia.

Objective: to analyze the trend of the diseases that aff ect the visual health and their economic impact on Colombian population. Methods: with the information from five national institutions that provided databases of people examined in 2011 and 2012 a database was built. With that unified information a retrospective analysis was done, that included the characterization of the population, diagnosis frequency, type and cost of the procedures. The diagnoses found were grouped according to the ICD-10 classification for eye diseases. The total number of registers was compared with data from the individual records of health service assistance for the same years, and an average cost per disease was obtained. Results: the total base analyzed consisted of 94 661 patients seen in 2011 and 73,433 patients in 2012. The patients included in this analysis correspond to 8.2% for 2011 and 9, 9% of total from the individual records of health service assistance for 2012. Distribution of the main outpatient diagnoses for the two years analyzed, showed that refractive disorders rank first followed by cataracts in both years. Conclusions: It is necessary to investigate the visual health state of a representative population in the country, in order to generate plans that promote the control, monitoring and prevention of eye diseases in Colombia.

Future perspectives for regenerative medicine in ophthalmology

Repair and reconstruction of the cornea has historically relied on synthetic materials or tissue transplantation. However, the future holds promise for treatments using smart biomaterials and stem cells that direct tissue repair and regeneration to ultimately create new ocular structures that are indistinguishable from the original native tissue. The cornea is a remarkable engineering structure. By understanding the physical structure of the tissue and the resulting impact of the structure on biological function, we can design novel materials for a number of ophthalmic clinical applications. Furthermore, by extending this structure-function approach to characterizing corneal disease processes, new therapies can be engineered

Vision-related research priorities and how to finance them.

A number of organizations have employed a consultative process with the vision community to engage relevant parties in identifying needs and opportunities for vision research. The National Eye Institute in the US and the European Commission are currently undergoing consultation to develop priorities for vision research. Once these priorities have been established, the challenge will be to identify the resources to advance these research agendas. Success rates for Federal funding for research have decreased recently in the USA, UK, and Australia. Researchers should consider various potential funding sources for their research. The universal consideration for funding is that the reason for funding should align with the mission of the funding organization. In addition to Federal research organizations that fund investigator-initiated research, other potential funding sources include nongovernmental organizations, for-profit companies, individual philanthropy, and service organizations. In addition to aligning with organizational funding priorities, researchers need to consider turn-around time and total funds available including whether an organization will cover institutional indirect costs. Websites are useful tools to find information about organizations that fund research, including grant deadlines. Collaboration is encouraged.